As pharmaceutical companies work to develop potential vaccines and treatments for COVID-19, they are operating under extreme pressure—as well as the restrictions on movement and interaction that are affecting all of us.
A greater share of Americans filed for unemployment insurance in the week ending March 21 than in any prior week in American history. We asked Yale SOM's Paul Goldsmith-Pinkham for his perspective on this alarming statistic.
The success of India’s Aadhaar, a biometrically secured national identification system, has ignited a debate over whether any entity, public or private, should have the ability to pool our full digital profiles.
On March 24, experts in finance, economics, and health from Global Network schools in seven countries gathered for an online conversation about the state of the COVID-19 pandemic, the economic fallout, and the path to recovery.
What will the sudden economic shock mean for competition and antitrust policy? We asked Yale SOM’s Fiona Scott Morton, an economist who served in the Antitrust Division of the U.S. Department of Justice, for her perspective.
Michael Apkon, Howard P. Forman, Jeffrey A. Sonnenfeld
In a Fortune commentary, Dr. Michael Apkon ’02, president and CEO of Tufts Medical Center, and Yale SOM’s Dr. Howard Forman and Jeffrey Sonnenfeld write that such an approach would be dangerous and ineffective.
The stock markets are reeling as fear and uncertainty about the global pandemic grow. We asked Yale SOM’s William Goetzmann, whose research includes financial history, to put the volatility into historical perspective.
We asked Yale SOM’s Nathan Novemsky, an expert in the psychology of judgment and decision-making, for his thoughts on how consumers are behaving during the COVID-19 pandemic and how they’re likely to view companies’ actions in the aftermath.
We asked Yale SOM’s James Choi, who has examined the implications of academic research for personal finance, what studies say about how to respond to a market crash.
